Indegene Ltd.

NSE: INDGN | BSE: 544172 | ISIN: INE065X01017 | Industry: Healthcare Services
| Mid-range Performer
573.8000 1.30 (0.23%)
NSE Aug 25, 2025 09:51 AM
Volume: 30,635
 

logo
Indegene Ltd.
03 May 2024
573.80
0.23%
HDFC Securities
IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products
Number of FII/FPI investors increased from 114 to 132 in Jun 2025 qtr.
More from Indegene Ltd.
Recommended